Evidence map›Paper›PMID 41480008›Full record

ArticleSynthetic and systems biotechnology2026

Enhancing delta-tocotrienol production in

Ziming Liu, Min Tang, Wanze Zhang, Yanjie Tian, Jianjun Qiao, Mingzhang Wen, Weiguo Li, Qinggele Caiyin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Synthetic and systems biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ziming LiuState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, 300072, China.
Min TangState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, 300072, China.
Wanze ZhangState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, 300072, China.
Yanjie TianState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, 300072, China.
Jianjun QiaoState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, 300072, China.
Mingzhang WenState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, 300072, China.
Weiguo LiState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, 300072, China.
Qinggele CaiyinState Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, 300072, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Delta (δ)-tocotrienol is a member of the vitamin E family and exhibits bioactivities such as antioxidant, anti-inflammatory, and neuroprotective activities. As a nutrient with protective effects on human health, δ-tocotrienol has broad application prospects in food, cosmetic, and pharmaceutical industries. The construction of efficient microbial cell factories capable of δ-tocotrienol production using synthetic biology approaches is an effective strategy for supplementing or even replacing the vitamin E supply chain in the future. The current study successfully enhanced the biosynthesis of δ-tocotrienol in

Indexed as

Microbial cell factoriesSaccharomyces cerevisiaeTocopherol cyclaseVitamin Eδ-tocotrienol

Identifiers

PMID41480008
PMCPMC12754398

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.